Chinese Journal of Tissue Engineering Research ›› 2023, Vol. 27 ›› Issue (20): 3230-3235.doi: 10.12307/2023.488

Previous Articles     Next Articles

Effects of Sanhua Jiegu San on Wnt/beta-catenin signaling pathway in osteoblasts

Duan Jiahao1, Tan Xuyi1, 2, Lu Min3, Kuang Gaoyan3, Fang Chuanlong4, Xiao Man4   

  1. 1Hunan University of Chinese Medicine, Changsha 410208, Hunan Province, China; 2Department of Orthopedics, Affiliated Hospital of Hunan Academy of Chinese Medical Science, Changsha 410006, Hunan Province, China; 3Department of Orthopedics, The First Hospital of Hunan University of Chinese Medicine, Changsha 410021, Hunan Province, China; 4Hunan Fangsheng Pharmaceutical Co., Ltd., Changsha 410205, Hunan Province, China
  • Received:2022-07-01 Accepted:2022-08-27 Online:2023-07-18 Published:2022-11-19
  • Contact: Tan Xuyi, MD, Associate chief physician, Hunan University of Chinese Medicine, Changsha 410208, Hunan Province, China; Department of Orthopedics, Affiliated Hospital of Hunan Academy of Chinese Medical Science, Changsha 410006, Hunan Province, China
  • About author:Duan Jiahao, MD candidate, Physician, Hunan University of Chinese Medicine, Changsha 410208, Hunan Province, China
  • Supported by:
    the Horizontal Project of Hunan University of Chinese Medicine

Abstract: BACKGROUND: Sanhua Jiegu San is a common drug for clinical fracture and tendon injury, which have good effect. However, there is a lack of relevant experimental evidence, and its mechanism of action remains unclear. 
OBJECTIVE: To observe the effect of Sanhua Jiegu San on Wnt/β-catenin signaling pathway in osteoblasts. 
METHODS: Firstly, the optimal concentration of Sanhua Jiegu San for osteoblast intervention was screened by pre-experiment. Then, the proliferation of osteoblasts was tested by cell counting kit-8 method. The maturity of osteoblasts was detected by alkaline phosphatase assay. The mRNA expressions of alkaline phosphatase, Runt-related transcription factor 2, osteocalcin, osteopontin, collagenase I, Axin2, Dkk4, Lef-1, and Tcf-1 were detected by PCR. The protein expressions of β-Catenin and P-β-Catenin were detected by western blot method. 
RESULTS AND CONCLUSION: After 5 days of osteoblast culture, the number of osteoblasts reached the maximum at the concentration of 10 mg/L. After 21 days of osteoblast culture, the proliferation of cells in different concentration groups of Sanhua Jiegu San increased, which was obvious in the 10 mg/L group, but tended to decrease at 20 mg/L. After 7 days of osteoblast culture, alkaline phosphatase expression was increased in the low, medium and high concentration groups, especially in the high concentration group (20 mg/L). After 7 days of osteoblast culture, mRNA expressions of alkaline phosphatase, Runt-related transcription factor 2, osteocalcin, osteopontin, collagenase I were increased in the low, medium and high concentration groups, especially in the high concentration group (20 mg/L). After 21 days of osteoblast culture, the mRNA expressions of Axin2 and Dkk4 were decreased in the low, medium and high concentration groups, while the mRNA expressions of Lef-1 and Tcf-1 were increased, especially in the high concentration group (20 mg/L). After 21 days of osteoblast culture, the expression of P-β-Catenin protein was decreased in the low, medium and high concentration groups, while the expression of β-Catenin protein was increased, especially in the high concentration group (20 mg/L). To conclude, Sanhua Jiegu San can regulate the Wnt/β-Catenin signaling pathway in osteoblasts, promote the mRNA expression of alkaline phosphatase, Runt-related transcription factor 2, osteocalcin, osteopontin, collagenase I, Lef-1, and Tcf-1 and the protein expression of β-Catenin, and decrease the mRNA expression of Axin2 and Dkk4 and the protein expression of P-β-Catenin, thereby promoting osteoblast proliferation. This may be the mechanism by which Sanhua Jiegu San promotes fracture healing.

Key words: Sanhua Jiegu San, osteoblast, cell proliferation, fracture healing, Wnt/β-catenin signaling pathway, molecular mechanism

CLC Number: